Abstract: A vehicle includes a battery including an all-solid-state battery configured to be externally chargeable with electric power supplied from outside of the vehicle, a heater configured to heat the battery, and a control device configured to control the heater. The control device controls the heater such that when a predetermined condition related to the external charging is satisfied, the temperature of the battery during execution of the external charging is higher than when the predetermined condition is not satisfied. The predetermined condition includes a condition that an elevation of the vehicle during the execution of the external charging is higher than a predetermined height.

Abstract: In the electrode laminate of the present disclosure, a fixing member including a curable resin is disposed on at least one side face portion. The fixing member has a thin film region and a thick film region. The thin film region is formed on at least one end portion including the terminal end of the fixing member, and the thick film region is formed at a portion other than the thin film region. The thickness of the fixing member is thinnest at the terminal end. Further, the battery of the present disclosure includes the electrode laminate of the present disclosure and a laminate film sealing the electrode laminate.

Abstract: Vehicles include a main battery, an auxiliary battery, charging relays, a DC/DC converter, and an ECU. The charging relay is used to perform external charging for charging the main battery by the power equipment. The DC/DC converter is configured to step down the discharging power of the main battery and to provide the stepped-down power to the auxiliary battery. ECU controls the DC/DC converter. ECU lowers the charging state of the auxiliary battery from the first state to the second state by the end of the external charging, and drives the DC/DC converter after the end of the external charging.

Abstract: A battery system includes a battery unit, a heater unit, and a sensor unit. The battery unit is accommodated in a battery case and includes sulfide-based all-solid-state batteries. The heater unit is configured to heat the battery unit. The sensor unit is configured to measure a hydrogen sulfide gas concentration inside the battery case. The heater unit is started to be driven when a measured value of the sensor unit becomes greater than the first threshold value. After starting the driving of the heater unit, when the measured value becomes greater than the second threshold value that is higher than the first threshold value, a responsive control is executed to deal with generation of the hydrogen sulfide gas from the sulfide-based all-solid-state batteries.

Abstract: A battery system includes a battery and an ECU. The ECU executes polarization cancellation control for canceling polarization of the battery and calculation processing for calculating SOC of the battery after the polarization cancellation control. When the polarization cancellation control is executed after the battery is discharged, the polarization cancellation control is charging control for charging the battery. When the polarization cancellation control is executed after the battery is charged, the polarization cancellation control is discharging control for discharging the battery.

Abstract: A method for therapeutic treatment of pain-associated anxiety or depression in a mammalian subject in need thereof, that includes administering to the subject an effective amount of a pharmaceutical composition containing a morphinan derivative that exhibits an opioid ? receptor agonist activity.

Abstract: The ECU performs a step of determining whether charging/discharging control is being executed, a step of acquiring the temperature of the terminal portion when it is determined that charging/discharging control is being executed, and a step of determining the charging power limit value, a step of setting a discharge power limit value, and a step of performing charge/discharge control using the set charge power limit value and the set discharge power limit value.

Abstract: A battery system includes at least one pack in which an all-solid-state battery cell is sealed, and a sensing unit configured to sense deformation of the at least one pack due to change in internal pressure of the at least one pack.

Abstract: A method for therapeutic treatment of pain-associated anxiety or depression in a mammalian subject in need thereof, that includes administering to the subject an effective amount of a pharmaceutical composition containing a morphinan derivative that exhibits an opioid ? receptor agonist activity.

Abstract: A vehicle on which an all-solid-state battery is mounted includes the all-solid-state battery, and a case that accommodates the all-solid-state battery. The vehicle is configured such that, when gas is generated in the case, a blocking process is executed to separate a vehicle cabin from outside air.

Abstract: A battery system includes: a battery case; a battery housed in the battery case, the battery being composed of a sulfide-based all-solid-state battery; a first detection unit located on a bottom surface of the battery case inside the battery case and configured to detect hydrogen sulfide; a second detection unit located vertically above the bottom surface inside the battery case and configured to detect hydrogen sulfide; and a control device. The control device includes an abnormality processing unit configured to perform an abnormality process based on detection results from the first detection unit and the second detection unit. The abnormality processing unit is configured to perform a first abnormality process when hydrogen sulfide is detected only by the first detection unit, and to perform a second abnormality process when hydrogen sulfide is detected by the second detection unit.

Abstract: A battery system includes a unit cell including a sulfide-based all-solid-state battery, a battery module in which a plurality of the unit cells is stacked between a pair of restraining members, an intermediate plate disposed between the stacked unit cells, a detection unit configured to detect a load applied to the intermediate plate, and an estimation unit configured to estimate generation of hydrogen sulfide in the unit cell, based on a change in load applied to the intermediate plate.

Abstract: A vehicle 1 equipped with an all-solid-state battery system includes a battery that is an all-solid-state battery, an electric heater that heats the battery, and an ECU that controls the electric heater. When charging of the battery is resumed after a pause shorter than a predetermined time, the ECU controls the electric heater to raise a temperature of the battery after resumption of the charging to a temperature higher than a temperature of the battery before the pause of the charging.

Abstract: A vehicle includes a battery including an all-solid-state battery configured to be externally chargeable with electric power supplied from outside of the vehicle, a heater configured to heat the battery, and a control device configured to control the heater. The control device controls the heater such that when a predetermined condition related to the external charging is satisfied, the temperature of the battery during execution of the external charging is higher than when the predetermined condition is not satisfied. The predetermined condition includes a condition that an elevation of the vehicle during the execution of the external charging is higher than a predetermined height.

Abstract: An all-solid-state battery comprises a power generation element and a restraint member. The restraint member applies a pressure of 0.5 MPa or less to the power generation element. The power generation element includes a positive electrode layer, a solid electrolyte layer, and a negative electrode layer. The solid electrolyte layer is interposed between the positive electrode layer and the negative electrode layer. The positive electrode layer includes a composite particle. The composite particle includes a positive electrode active material particle and a covering layer. The covering layer covers at least part of a surface of the positive electrode active material particle. The covering layer includes a sulfide solid electrolyte.

Abstract: The present invention aims to provide a novel low-molecular-weight compound showing an orexin receptor agonist activity and expected to be useful as a prophylactic or therapeutic agent for narcolepsy and the like. The present invention provides a compound represented by the formula (I): wherein each symbol is as described in the description, or a pharmaceutically acceptable acid addition salt thereof, which has an orexin receptor agonist activity, and an orexin receptor agonist containing the compound or a pharmaceutically acceptable acid addition salt thereof.

Abstract: A morphinan derivative represented by the following general formula (I): wherein R1 represents hydrogen, C1-10 alkyl, cycloalkylalkyl where the cycloalkyl moiety has 3 to 6 carbon atoms, and the alkylene moiety has 1 to 5 carbon atoms, etc.; R2 represents heterocyclic ring containing 1 to 4 heteroatoms selected from N, O and S and at least one carbon atom as ring-constituting atoms, containing at least one set of adjacent ring-constituting atoms bound by a double bond, and further substituted with at least one oxo group; Y binds to a carbon atom as a ring-constituting atom of R2; R3, R4, and R5 represent hydrogen, hydroxy, etc.; R6a and R6b represent hydrogen, etc.; R7 and R8 represent hydrogen, etc.; R9 and R10, which are the same or different, represent hydrogen, etc.; X represents O or CH2; and Y represents C(?O)); a tautomer or stereoisomer of the compound, or a pharmaceutically acceptable salt thereof, or a solvate thereof is used as an anxiolytic drug, antidepressant, etc.

Abstract: A morphinan derivative represented by the following general formula (I): wherein R1 represents hydrogen, C1-10 alkyl, cycloalkylalkyl where the cycloalkyl moiety has 3 to 6 carbon atoms, and the alkylene moiety has 1 to 5 carbon atoms, etc.; R2 represents heterocyclic ring containing 1 to 4 heteroatoms selected from N, O and S and at least one carbon atom as ring-constituting atoms, containing at least one set of adjacent ring-constituting atoms bound by a double bond, and further substituted with at least one oxo group; Y binds to a carbon atom as a ring-constituting atom of R2; R3, R4, and R5 represent hydrogen, hydroxy, etc.; R6a and R6b represent hydrogen, etc.; R7 and R8 represent hydrogen, etc.; R9 and R10, which are the same or different, represent hydrogen, etc.; X represents O or CH2; and Y represents C(?O)); a tautomer or stereoisomer of the compound, or a pharmaceutically acceptable salt thereof, or a solvate thereof is used as an anxiolytic drug, antidepressant, etc.

Abstract: A method for therapeutic treatment of pain-associated anxiety or depression in a mammalian subject in need thereof, that includes administering to the subject an effective amount of a pharmaceutical composition containing a morphinan derivative that exhibits an opioid ? receptor agonist activity.

Abstract: The present invention relates to a pharmaceutical composition comprising a morphinan derivative that exhibits an opioid ? receptor agonist activity. By administering the pharmaceutical composition provided by the present invention, opioid ? receptor-related diseases (for example, headache) can be treated or prevented.